These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
o
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Virginia
|
52-1549373
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
|
|
|
4991 Lake Brook Drive, Suite 100, Glen Allen, Virginia
|
23060-9245
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
|
|
(804) 217-5800
(Registrant’s telephone number, including area code)
|
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
x
|
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
|
Emerging growth company
|
o
|
|
|
|
|
Page
|
|
|
|||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
Consolidated Balance Sheets as of September 30, 2017 (unaudited) and December 31, 2016
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2017 (unaudited) and September 30, 2016 (unaudited)
|
|
|
|
|
|
|
|
|
|
Consolidated Statement of Shareholders' Equity for the nine months ended September 30, 2017 (unaudited)
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 (unaudited) and September 30, 2016 (unaudited)
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
ASSETS
|
(unaudited)
|
|
|
||||
|
Mortgage-backed securities (including pledged of $2,714,312 and $3,150,610, respectively)
|
$
|
2,921,444
|
|
|
$
|
3,212,084
|
|
|
Mortgage loans held for investment, net
|
16,523
|
|
|
19,036
|
|
||
|
Cash and cash equivalents
|
117,702
|
|
|
74,120
|
|
||
|
Restricted cash
|
43,987
|
|
|
24,769
|
|
||
|
Derivative assets
|
368
|
|
|
28,534
|
|
||
|
Receivable for securities sold
|
13,435
|
|
|
—
|
|
||
|
Principal receivable on investments
|
3,359
|
|
|
11,978
|
|
||
|
Accrued interest receivable
|
19,267
|
|
|
20,396
|
|
||
|
Other assets, net
|
7,193
|
|
|
6,814
|
|
||
|
Total assets
|
$
|
3,143,278
|
|
|
$
|
3,397,731
|
|
|
|
|
|
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Liabilities:
|
|
|
|
|
|
||
|
Repurchase agreements
|
$
|
2,519,230
|
|
|
$
|
2,898,952
|
|
|
Payable for unsettled securities
|
77,357
|
|
|
—
|
|
||
|
Non-recourse collateralized financing
|
5,706
|
|
|
6,440
|
|
||
|
Derivative liabilities
|
133
|
|
|
6,922
|
|
||
|
Accrued interest payable
|
2,720
|
|
|
3,156
|
|
||
|
Accrued dividends payable
|
11,620
|
|
|
12,268
|
|
||
|
Other liabilities
|
2,413
|
|
|
2,809
|
|
||
|
Total liabilities
|
2,619,179
|
|
|
2,930,547
|
|
||
|
|
|
|
|
|
|||
|
Shareholders’ equity:
|
|
|
|
|
|
||
|
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 5,665,101 and 4,571,937 shares issued and outstanding, respectively ($141,628 and $114,298 aggregate liquidation preference, respectively)
|
$
|
135,828
|
|
|
$
|
110,005
|
|
|
Common stock, par value $.01 per share, 200,000,000 shares authorized;
51,262,350 and 49,153,463 shares issued and outstanding, respectively
|
513
|
|
|
492
|
|
||
|
Additional paid-in capital
|
742,845
|
|
|
727,369
|
|
||
|
Accumulated other comprehensive income (loss)
|
5,886
|
|
|
(32,609
|
)
|
||
|
Accumulated deficit
|
(360,973
|
)
|
|
(338,073
|
)
|
||
|
Total shareholders' equity
|
524,099
|
|
|
467,184
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
3,143,278
|
|
|
$
|
3,397,731
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Interest income
|
$
|
23,103
|
|
|
$
|
21,135
|
|
|
$
|
70,378
|
|
|
69,040
|
|
|
|
Interest expense
|
9,889
|
|
|
6,068
|
|
|
26,122
|
|
|
18,478
|
|
||||
|
Net interest income
|
13,214
|
|
|
15,067
|
|
|
44,256
|
|
|
50,562
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Gain (loss) on derivative instruments, net
|
5,993
|
|
|
2,409
|
|
|
(9,634
|
)
|
|
(62,153
|
)
|
||||
|
Loss on sale of investments, net
|
(5,211
|
)
|
|
—
|
|
|
(10,628
|
)
|
|
(4,238
|
)
|
||||
|
Fair value adjustments, net
|
23
|
|
|
34
|
|
|
63
|
|
|
86
|
|
||||
|
Other (loss) income, net
|
(109
|
)
|
|
545
|
|
|
(150
|
)
|
|
898
|
|
||||
|
General and administrative expenses:
|
|
|
|
|
|
|
|
|
|||||||
|
Compensation and benefits
|
(2,070
|
)
|
|
(1,736
|
)
|
|
(6,356
|
)
|
|
(5,829
|
)
|
||||
|
Other general and administrative
|
(1,529
|
)
|
|
(1,619
|
)
|
|
(5,620
|
)
|
|
(5,288
|
)
|
||||
|
Net income (loss)
|
10,311
|
|
|
14,700
|
|
|
11,931
|
|
|
(25,962
|
)
|
||||
|
Preferred stock dividends
|
(2,808
|
)
|
|
(2,294
|
)
|
|
(7,885
|
)
|
|
(6,882
|
)
|
||||
|
Net income (loss) to common shareholders
|
$
|
7,503
|
|
|
$
|
12,406
|
|
|
$
|
4,046
|
|
|
$
|
(32,844
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|||||||
|
Unrealized gain on available-for-sale investments, net
|
$
|
981
|
|
|
$
|
769
|
|
|
$
|
28,087
|
|
|
$
|
61,260
|
|
|
Reclassification adjustment for loss on sale of investments, net
|
5,211
|
|
|
—
|
|
|
10,628
|
|
|
4,238
|
|
||||
|
Reclassification adjustment for de-designated cash flow hedges
|
(48
|
)
|
|
(99
|
)
|
|
(220
|
)
|
|
(152
|
)
|
||||
|
Total other comprehensive income
|
6,144
|
|
|
670
|
|
|
38,495
|
|
|
65,346
|
|
||||
|
Comprehensive income to common shareholders
|
$
|
13,647
|
|
|
$
|
13,076
|
|
|
$
|
42,541
|
|
|
$
|
32,502
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per common share-basic and diluted
|
$
|
0.15
|
|
|
$
|
0.25
|
|
|
$
|
0.08
|
|
|
$
|
(0.67
|
)
|
|
Weighted average common shares-basic and diluted
|
49,832
|
|
|
49,147
|
|
|
49,411
|
|
|
49,102
|
|
||||
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Other
Comprehensive
(Loss) Income
|
|
Accumulated
Deficit
|
|
Total Shareholders' Equity
|
||||||||||||||||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||
|
Balance as of December 31, 2016
|
4,571,937
|
|
$
|
110,005
|
|
|
49,153,463
|
|
$
|
492
|
|
|
$
|
727,369
|
|
|
$
|
(32,609
|
)
|
|
$
|
(338,073
|
)
|
|
$
|
467,184
|
|
|
Stock issuance
|
1,093,164
|
|
25,884
|
|
|
2,048,288
|
|
21
|
|
|
14,474
|
|
|
—
|
|
|
—
|
|
|
40,379
|
|
||||||
|
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
138,166
|
|
1
|
|
|
1,565
|
|
|
—
|
|
|
—
|
|
|
1,566
|
|
||||||
|
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(77,567
|
)
|
(1
|
)
|
|
(520
|
)
|
|
—
|
|
|
—
|
|
|
(521
|
)
|
||||||
|
Stock issuance costs
|
—
|
|
(61
|
)
|
|
—
|
|
—
|
|
|
(43
|
)
|
|
—
|
|
|
—
|
|
|
(104
|
)
|
||||||
|
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,931
|
|
|
11,931
|
|
||||||
|
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,885
|
)
|
|
(7,885
|
)
|
||||||
|
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(26,946
|
)
|
|
(26,946
|
)
|
||||||
|
Other comprehensive income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
38,495
|
|
|
—
|
|
|
38,495
|
|
||||||
|
Balance as of September 30, 2017
|
5,665,101
|
|
$
|
135,828
|
|
|
51,262,350
|
|
$
|
513
|
|
|
$
|
742,845
|
|
|
$
|
5,886
|
|
|
$
|
(360,973
|
)
|
|
$
|
524,099
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Operating activities:
|
|
|
|
||||
|
Net income (loss)
|
$
|
11,931
|
|
|
$
|
(25,962
|
)
|
|
Adjustments to reconcile net income (loss) to cash provided by operating activities:
|
|
|
|
|
|
||
|
Decrease in accrued interest receivable
|
1,129
|
|
|
3,263
|
|
||
|
(Decrease) increase in accrued interest payable
|
(436
|
)
|
|
420
|
|
||
|
Loss on derivative instruments, net
|
9,634
|
|
|
62,153
|
|
||
|
Loss on sale of investments, net
|
10,628
|
|
|
4,238
|
|
||
|
Fair value adjustments, net
|
(63
|
)
|
|
(86
|
)
|
||
|
Amortization of investment premiums, net
|
122,621
|
|
|
112,418
|
|
||
|
Other amortization and depreciation, net
|
983
|
|
|
1,186
|
|
||
|
Stock-based compensation expense
|
1,567
|
|
|
2,066
|
|
||
|
Increase in other assets and liabilities, net
|
(1,905
|
)
|
|
(2,060
|
)
|
||
|
Net cash and cash equivalents provided by operating activities
|
156,089
|
|
|
157,636
|
|
||
|
Investing activities:
|
|
|
|
|
|
||
|
Purchase of investments
|
(772,590
|
)
|
|
(96,816
|
)
|
||
|
Principal payments received on investments
|
248,298
|
|
|
337,719
|
|
||
|
Proceeds from sales of investments
|
792,984
|
|
|
94,033
|
|
||
|
Principal payments received on mortgage loans held for investment, net
|
2,641
|
|
|
3,709
|
|
||
|
Distributions received from limited partnership
|
—
|
|
|
10,835
|
|
||
|
Net receipts (payments) on derivatives, including terminations
|
11,743
|
|
|
(24,483
|
)
|
||
|
Other investing activities
|
(214
|
)
|
|
(105
|
)
|
||
|
Net cash and cash equivalents provided by investing activities
|
282,862
|
|
|
324,892
|
|
||
|
Financing activities:
|
|
|
|
|
|
||
|
Borrowings under repurchase agreements
|
60,229,426
|
|
|
19,293,243
|
|
||
|
Repayments of repurchase agreement borrowings and FHLB advances
|
(60,609,148
|
)
|
|
(19,661,384
|
)
|
||
|
Principal payments on non-recourse collateralized financing
|
(747
|
)
|
|
(1,443
|
)
|
||
|
Proceeds from issuance of preferred stock
|
25,884
|
|
|
—
|
|
||
|
Proceeds from issuance of common stock
|
14,495
|
|
|
102
|
|
||
|
Cash paid for stock issuance costs
|
(61
|
)
|
|
—
|
|
||
|
Cash paid for repurchases of common stock
|
—
|
|
|
(310
|
)
|
||
|
Payments related to tax withholding for stock-based compensation
|
(521
|
)
|
|
(485
|
)
|
||
|
Dividends paid
|
(35,479
|
)
|
|
(39,285
|
)
|
||
|
Net cash and cash equivalents used in financing activities
|
(376,151
|
)
|
|
(409,562
|
)
|
||
|
|
|
|
|
||||
|
Net increase in cash, cash equivalents, and restricted cash
|
62,800
|
|
|
72,966
|
|
||
|
Cash, cash equivalents, and restricted cash at beginning of period
|
98,889
|
|
|
85,125
|
|
||
|
Cash, cash equivalents, and restricted cash at end of period
|
$
|
161,689
|
|
|
$
|
158,091
|
|
|
Supplemental Disclosure of Cash Activity:
|
|
|
|
|
|
||
|
Cash paid for interest
|
$
|
26,766
|
|
|
$
|
18,185
|
|
|
|
|
September 30, 2017
|
||
|
Cash and cash equivalents
|
|
$
|
117,702
|
|
|
Restricted cash
|
|
43,987
|
|
|
|
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows
|
|
$
|
161,689
|
|
|
|
September 30, 2017
|
|||||||||||||||||||||||||
|
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
(1)
|
|||||||||||||
|
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Agency
|
$
|
1,302,237
|
|
|
$
|
12,688
|
|
|
1,314,925
|
|
|
$
|
6,187
|
|
|
$
|
(13,623
|
)
|
|
1,307,489
|
|
|
2.99
|
%
|
||
|
Non-Agency
|
40,780
|
|
|
(4,452
|
)
|
|
36,328
|
|
|
2,877
|
|
|
—
|
|
|
39,205
|
|
|
5.48
|
%
|
||||||
|
|
1,343,017
|
|
|
8,236
|
|
|
1,351,253
|
|
|
9,064
|
|
|
(13,623
|
)
|
|
1,346,694
|
|
|
|
|||||||
|
CMBS IO
(2)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Agency
|
—
|
|
|
394,380
|
|
|
394,380
|
|
|
7,592
|
|
|
(164
|
)
|
|
401,808
|
|
|
0.63
|
%
|
||||||
|
Non-Agency
|
—
|
|
|
322,735
|
|
|
322,735
|
|
|
6,254
|
|
|
(330
|
)
|
|
328,659
|
|
|
0.61
|
%
|
||||||
|
|
—
|
|
|
717,115
|
|
|
717,115
|
|
|
13,846
|
|
|
(494
|
)
|
|
730,467
|
|
|
|
|||||||
|
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Agency fixed-rate
|
522,099
|
|
|
19,163
|
|
|
541,262
|
|
|
—
|
|
|
(1,903
|
)
|
|
539,359
|
|
|
3.52
|
%
|
||||||
|
Agency adjustable-rate
|
294,254
|
|
|
11,011
|
|
|
305,265
|
|
|
1,263
|
|
|
(2,746
|
)
|
|
303,782
|
|
|
3.05
|
%
|
||||||
|
Non-Agency
|
1,113
|
|
|
—
|
|
|
1,113
|
|
|
49
|
|
|
(20
|
)
|
|
1,142
|
|
|
6.75
|
%
|
||||||
|
|
817,466
|
|
|
30,174
|
|
|
847,640
|
|
|
1,312
|
|
|
(4,669
|
)
|
|
844,283
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total AFS securities:
|
$
|
2,160,483
|
|
|
$
|
755,525
|
|
|
$
|
2,916,008
|
|
|
$
|
24,222
|
|
|
$
|
(18,786
|
)
|
|
$
|
2,921,444
|
|
|
|
|
|
(1)
|
The weighted average coupon ("WAC") is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
|
(2)
|
The notional balance for Agency CMBS IO and non-Agency CMBS IO was
$14,253,392
and
$11,061,377
, respectively, as of
September 30, 2017
.
|
|
|
December 31, 2016
|
|||||||||||||||||||||||||
|
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
(1)
|
|||||||||||||
|
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Agency
|
$
|
1,152,586
|
|
|
$
|
13,868
|
|
|
$
|
1,166,454
|
|
|
$
|
6,209
|
|
|
$
|
(28,108
|
)
|
|
$
|
1,144,555
|
|
|
3.12
|
%
|
|
Non-Agency
|
79,467
|
|
|
(6,718
|
)
|
|
72,749
|
|
|
5,467
|
|
|
—
|
|
|
78,216
|
|
|
4.72
|
%
|
||||||
|
|
1,232,053
|
|
|
7,150
|
|
|
1,239,203
|
|
|
11,676
|
|
|
(28,108
|
)
|
|
1,222,771
|
|
|
|
|||||||
|
CMBS IO
(2)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Agency
|
—
|
|
|
411,737
|
|
|
411,737
|
|
|
3,523
|
|
|
(3,362
|
)
|
|
411,898
|
|
|
0.67
|
%
|
||||||
|
Non-Agency
|
—
|
|
|
346,155
|
|
|
346,155
|
|
|
1,548
|
|
|
(5,055
|
)
|
|
342,648
|
|
|
0.61
|
%
|
||||||
|
|
—
|
|
|
757,892
|
|
|
757,892
|
|
|
5,071
|
|
|
(8,417
|
)
|
|
754,546
|
|
|
|
|||||||
|
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Agency adjustable-rate
|
$
|
1,157,258
|
|
|
$
|
57,066
|
|
|
$
|
1,214,324
|
|
|
$
|
2,832
|
|
|
$
|
(15,951
|
)
|
|
$
|
1,201,205
|
|
|
3.05
|
%
|
|
Non-Agency
|
33,572
|
|
|
(24
|
)
|
|
33,548
|
|
|
64
|
|
|
(50
|
)
|
|
33,562
|
|
|
3.58
|
%
|
||||||
|
|
1,190,830
|
|
|
57,042
|
|
|
1,247,872
|
|
|
2,896
|
|
|
(16,001
|
)
|
|
1,234,767
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Total AFS securities:
|
$
|
2,422,883
|
|
|
$
|
822,084
|
|
|
$
|
3,244,967
|
|
|
$
|
19,643
|
|
|
$
|
(52,526
|
)
|
|
$
|
3,212,084
|
|
|
|
|
|
(1)
|
The WAC is the gross interest rate of the pool of mortgages underlying the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
|
(2)
|
The notional balance for the Agency CMBS IO and non-Agency CMBS IO was
$13,106,912
and
$10,884,964
, respectively, as of
December 31, 2016
.
|
|
|
Three Months Ended
|
||||||||||||||
|
|
September 30,
|
||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
||||||||
|
Agency RMBS
|
$
|
393,502
|
|
|
$
|
(5,160
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Agency CMBS
|
13,433
|
|
|
(51
|
)
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
406,935
|
|
|
$
|
(5,211
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Nine Months Ended
|
||||||||||||||
|
|
September 30,
|
||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
||||||||
|
Agency RMBS
|
$
|
716,560
|
|
|
$
|
(12,392
|
)
|
|
$
|
54,178
|
|
|
$
|
(3,010
|
)
|
|
Agency CMBS
|
206,993
|
|
|
523
|
|
|
—
|
|
|
—
|
|
||||
|
Non-Agency CMBS
|
35,705
|
|
|
1,199
|
|
|
33,640
|
|
|
(1,228
|
)
|
||||
|
Non-Agency RMBS
|
16,407
|
|
|
42
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
975,665
|
|
|
$
|
(10,628
|
)
|
|
$
|
87,818
|
|
|
$
|
(4,238
|
)
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||||||
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
||||||||
|
Continuous unrealized loss position for less than 12 months:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Agency MBS
|
$
|
1,377,438
|
|
|
$
|
(13,201
|
)
|
|
76
|
|
$
|
1,738,094
|
|
|
$
|
(38,469
|
)
|
|
133
|
|
Non-Agency MBS
|
38,979
|
|
|
(151
|
)
|
|
6
|
|
205,484
|
|
|
(2,773
|
)
|
|
48
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Continuous unrealized loss position for 12 months or longer:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Agency MBS
|
$
|
206,045
|
|
|
$
|
(5,236
|
)
|
|
17
|
|
$
|
427,405
|
|
|
$
|
(8,952
|
)
|
|
72
|
|
Non-Agency MBS
|
15,749
|
|
|
(199
|
)
|
|
11
|
|
81,660
|
|
|
(2,332
|
)
|
|
26
|
||||
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||||||||
|
Collateral Type
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
||||||||||
|
Agency CMBS
|
|
$
|
1,188,230
|
|
|
1.31
|
%
|
|
$
|
1,250,575
|
|
|
$
|
1,005,726
|
|
|
0.82
|
%
|
|
$
|
1,095,002
|
|
|
Non-Agency CMBS
|
|
15,625
|
|
|
2.14
|
%
|
|
18,365
|
|
|
66,881
|
|
|
1.63
|
%
|
|
77,840
|
|
||||
|
Agency CMBS IO
|
|
336,187
|
|
|
2.06
|
%
|
|
389,637
|
|
|
346,892
|
|
|
1.57
|
%
|
|
407,481
|
|
||||
|
Non-Agency CMBS IO
|
|
279,981
|
|
|
2.15
|
%
|
|
327,976
|
|
|
291,199
|
|
|
1.67
|
%
|
|
341,139
|
|
||||
|
Agency RMBS
|
|
695,841
|
|
|
1.31
|
%
|
|
727,727
|
|
|
1,157,302
|
|
|
0.82
|
%
|
|
1,191,147
|
|
||||
|
Non-Agency RMBS
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
26,149
|
|
|
1.98
|
%
|
|
31,952
|
|
||||
|
Securitization financing bond
|
|
3,366
|
|
|
2.58
|
%
|
|
3,723
|
|
|
4,803
|
|
|
2.00
|
%
|
|
5,278
|
|
||||
|
Total repurchase agreements
|
|
$
|
2,519,230
|
|
|
1.51
|
%
|
|
$
|
2,718,003
|
|
|
$
|
2,898,952
|
|
|
1.03
|
%
|
|
$
|
3,149,839
|
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||
|
Remaining Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
||||||
|
Less than 30 days
|
|
$
|
1,725,518
|
|
|
36
|
|
|
$
|
2,480,213
|
|
|
58
|
|
|
30 to 90 days
|
|
793,712
|
|
|
89
|
|
|
418,739
|
|
|
87
|
|
||
|
Total
|
|
$
|
2,519,230
|
|
|
53
|
|
|
$
|
2,898,952
|
|
|
63
|
|
|
|
|
September 30, 2017
|
|||||||||
|
Counterparty Name
|
|
Balance
|
|
Weighted Average Rate
|
|
Equity at Risk
|
|||||
|
Wells Fargo Bank, N. A. and affiliates
|
|
$
|
349,965
|
|
|
2.10
|
%
|
|
$
|
57,992
|
|
|
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
|
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
|
September 30, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Repurchase agreements
|
$
|
2,519,230
|
|
|
$
|
—
|
|
|
$
|
2,519,230
|
|
|
$
|
(2,519,230
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Repurchase agreements
|
$
|
2,898,952
|
|
|
$
|
—
|
|
|
$
|
2,898,952
|
|
|
$
|
(2,898,952
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.
|
|
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Type of Derivative Instruments
|
|
Balance Sheet Location
|
|
Fair Value
|
|
Fair Value
(1)
|
||||
|
Interest rate swaps
|
|
Derivative assets
|
|
$
|
368
|
|
|
$
|
28,534
|
|
|
TBA securities
|
|
Derivative assets
|
|
—
|
|
|
—
|
|
||
|
|
|
|
|
$
|
368
|
|
|
$
|
28,534
|
|
|
|
|
|
|
|
|
|
||||
|
Interest rate swaps
|
|
Derivative liabilities
|
|
$
|
—
|
|
|
$
|
(6,922
|
)
|
|
TBA securities
|
|
Derivative liabilities
|
|
(133
|
)
|
|
—
|
|
||
|
|
|
|
|
$
|
(133
|
)
|
|
$
|
(6,922
|
)
|
|
(1)
|
Refer to
Note 1
regarding information on a change in the CME rulebook. Amounts reported on the consolidated balance sheet as of
September 30, 2017
for its interest rate swaps reflect the netting of the derivative asset or liability with the related collateral received or posted, respectively. The net amounts comparable to
September 30, 2017
for the derivative asset and derivative liabilities as of December 31, 2016 were
$104
and
$(576)
, respectively.
|
|
|
|
September 30, 2017
|
|||||||||||
|
|
|
|
|
Weighted-Average:
|
|
|
|||||||
|
Years to Maturity:
|
|
Net Notional Amount
(1)
|
|
Pay Rate
(2)
|
|
Life Remaining (in Years)
|
|
Fair Value
|
|||||
|
<
3 years
|
|
$
|
3,110,000
|
|
|
1.39
|
%
|
|
0.9
|
|
$
|
368
|
|
|
>3 and
<
6 years
|
|
1,160,000
|
|
|
1.66
|
%
|
|
4.2
|
|
—
|
|
||
|
>6 and
<
10 years
|
|
1,175,000
|
|
|
2.45
|
%
|
|
8.1
|
|
—
|
|
||
|
Total
|
|
$
|
5,445,000
|
|
|
1.68
|
%
|
|
3.2
|
|
$
|
368
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
December 31, 2016
|
|||||||||||
|
|
|
|
|
Weighted-Average:
|
|
|
|||||||
|
Years to Maturity:
|
|
Net Notional Amount
(1)
|
|
Pay Rate
(2)
|
|
Life Remaining (in Years)
|
|
Fair Value
|
|||||
|
<
3 years
|
|
$
|
595,000
|
|
|
0.73
|
%
|
|
2.3
|
|
$
|
4,348
|
|
|
>3 and
<
6 years
|
|
1,185,000
|
|
|
1.47
|
%
|
|
4.3
|
|
8,631
|
|
||
|
>6 and
<
10 years
|
|
1,250,000
|
|
|
2.42
|
%
|
|
8.9
|
|
8,633
|
|
||
|
Total
|
|
$
|
3,030,000
|
|
|
1.58
|
%
|
|
5.3
|
|
$
|
21,612
|
|
|
(1)
|
The net notional amounts included in the tables above represent pay-fixed interest rate swaps, net of receive-fixed interest rate swaps and include
$2,425,000
and
$2,725,000
of pay-fixed forward starting interest rate swaps as of
September 30, 2017
and
December 31, 2016
, respectively.
|
|
|
|
September 30, 2017
|
||||||||||||||
|
|
|
Notional Amount
(1)
|
|
Cost Basis
(2)
|
|
Market Value
(3)
|
|
Net Carrying Value
(4)
|
||||||||
|
30-year 4.0% TBA securities
|
|
$
|
650,000
|
|
|
$
|
683,813
|
|
|
$
|
683,680
|
|
|
$
|
(133
|
)
|
|
(1)
|
Notional amount represents the par value (or principal balance) of the underlying Agency MBS.
|
|
(2)
|
Cost basis represents the forward price to be paid for the underlying Agency MBS as if settled.
|
|
(3)
|
Market value is the current fair value of the TBA contract and represents the estimated fair value of the underlying Agency security as of the end of the period.
|
|
(4)
|
Net carrying value represents the difference between the market value and the cost basis of the TBA contract as of the end of the period and is included on the consolidated balance sheets within "derivative assets (liabilities)".
|
|
Type of Derivative Instrument
|
|
Notional Amount as of December 31, 2016
|
|
Additions
|
|
Settlements,
Terminations,
or Pair-Offs
|
|
Notional Amount as of September 30, 2017
|
||||||||
|
Receive-fixed interest rate swaps
|
|
$
|
425,000
|
|
|
$
|
—
|
|
|
$
|
(325,000
|
)
|
|
$
|
100,000
|
|
|
Pay-fixed interest rate swaps
|
|
3,455,000
|
|
|
3,010,000
|
|
|
(920,000
|
)
|
|
5,545,000
|
|
||||
|
TBA securities
|
|
—
|
|
|
3,814,000
|
|
|
(3,164,000
|
)
|
|
650,000
|
|
||||
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
Type of Derivative Instrument
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Receive-fixed interest rate swaps
|
|
$
|
(99
|
)
|
|
$
|
(2,976
|
)
|
|
$
|
746
|
|
|
$
|
11,301
|
|
|
Pay-fixed interest rate swaps
|
|
(611
|
)
|
|
2,555
|
|
|
(18,799
|
)
|
|
(59,912
|
)
|
||||
|
TBA securities
|
|
6,703
|
|
|
—
|
|
|
8,419
|
|
|
—
|
|
||||
|
Eurodollar futures
|
|
—
|
|
|
2,830
|
|
|
—
|
|
|
(13,542
|
)
|
||||
|
Gain (loss) on derivative instruments, net
|
|
$
|
5,993
|
|
|
$
|
2,409
|
|
|
$
|
(9,634
|
)
|
|
$
|
(62,153
|
)
|
|
|
Offsetting of Assets
|
||||||||||||||||||||||
|
|
Gross Amount of Recognized Assets
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Assets Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
|
Financial Instruments Received as Collateral
|
|
Cash Received as Collateral
|
|||||||||||||||||||||
|
September 30, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate swaps
|
$
|
368
|
|
|
$
|
—
|
|
|
$
|
368
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
368
|
|
|
TBA securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Derivative assets
|
$
|
368
|
|
|
$
|
—
|
|
|
$
|
368
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
368
|
|
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate swaps
|
$
|
28,534
|
|
|
$
|
—
|
|
|
$
|
28,534
|
|
|
$
|
(6,449
|
)
|
|
$
|
(22,085
|
)
|
|
$
|
—
|
|
|
TBA securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Derivative assets
|
$
|
28,534
|
|
|
$
|
—
|
|
|
$
|
28,534
|
|
|
$
|
(6,449
|
)
|
|
$
|
(22,085
|
)
|
|
$
|
—
|
|
|
|
Offsetting of Liabilities
|
||||||||||||||||||||||
|
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
|
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
|
September 30, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate swaps
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
TBA securities
|
133
|
|
|
—
|
|
|
133
|
|
|
—
|
|
|
(63
|
)
|
|
70
|
|
||||||
|
Derivative liabilities
|
$
|
133
|
|
|
$
|
—
|
|
|
$
|
133
|
|
|
$
|
—
|
|
|
$
|
(63
|
)
|
|
$
|
70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate swaps
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
(6,913
|
)
|
|
$
|
—
|
|
|
$
|
9
|
|
|
TBA securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Derivative liabilities
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
(6,913
|
)
|
|
$
|
—
|
|
|
$
|
9
|
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.
|
|
•
|
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
|
|
•
|
Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
|
|
•
|
Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
|
|
|
September 30, 2017
|
||||||||||||||
|
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Mortgage-backed securities
|
$
|
2,921,444
|
|
|
$
|
—
|
|
|
$
|
2,913,877
|
|
|
$
|
7,567
|
|
|
Interest rate swaps
|
368
|
|
|
—
|
|
|
368
|
|
|
—
|
|
||||
|
Total assets carried at fair value
|
$
|
2,921,812
|
|
|
$
|
—
|
|
|
$
|
2,914,245
|
|
|
$
|
7,567
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
TBA securities
|
133
|
|
|
—
|
|
|
133
|
|
|
—
|
|
||||
|
Total liabilities carried at fair value
|
$
|
133
|
|
|
$
|
—
|
|
|
$
|
133
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
December 31, 2016
|
||||||||||||||
|
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Mortgage-backed securities
|
$
|
3,212,084
|
|
|
$
|
—
|
|
|
$
|
3,201,157
|
|
|
$
|
10,927
|
|
|
Interest rate swaps
|
28,534
|
|
|
—
|
|
|
28,534
|
|
|
—
|
|
||||
|
Total assets carried at fair value
|
$
|
3,240,618
|
|
|
$
|
—
|
|
|
$
|
3,229,691
|
|
|
$
|
10,927
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Interest rate swaps
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
—
|
|
|
Total liabilities carried at fair value
|
$
|
6,922
|
|
|
$
|
—
|
|
|
$
|
6,922
|
|
|
$
|
—
|
|
|
|
Level 3 Fair Value
|
||||||||||
|
|
Non-Agency CMBS
|
|
Non-Agency RMBS
|
|
Total
|
||||||
|
Balance as of December 31, 2016
|
$
|
9,669
|
|
|
$
|
1,258
|
|
|
$
|
10,927
|
|
|
Unrealized loss included in OCI
(1)
|
(1,422
|
)
|
|
16
|
|
|
(1,406
|
)
|
|||
|
Principal payments
|
(3,896
|
)
|
|
(133
|
)
|
|
(4,029
|
)
|
|||
|
Accretion
|
2,075
|
|
|
—
|
|
|
2,075
|
|
|||
|
Balance as of September 30, 2017
|
$
|
6,426
|
|
|
$
|
1,141
|
|
|
$
|
7,567
|
|
|
(1)
|
Amount included in "unrealized gain on available-for-sale investments, net" on consolidated statements of comprehensive income (loss).
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Mortgage-backed securities
|
$
|
2,921,444
|
|
|
$
|
2,921,444
|
|
|
$
|
3,212,084
|
|
|
$
|
3,212,084
|
|
|
Mortgage loans held for investment, net
(1)
|
16,523
|
|
|
13,674
|
|
|
19,036
|
|
|
15,971
|
|
||||
|
Derivative assets
|
368
|
|
|
368
|
|
|
28,534
|
|
|
28,534
|
|
||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Repurchase agreements
(2)
|
$
|
2,519,230
|
|
|
$
|
2,519,230
|
|
|
$
|
2,898,952
|
|
|
$
|
2,898,952
|
|
|
Non-recourse collateralized financing
(1)
|
5,706
|
|
|
5,722
|
|
|
6,440
|
|
|
6,357
|
|
||||
|
Derivative liabilities
|
133
|
|
|
133
|
|
|
6,922
|
|
|
6,922
|
|
||||
|
(1)
|
The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company's Level 3 non-Agency MBS.
|
|
(2)
|
The carrying value of repurchase agreements generally approximates fair value due to their short term maturities.
|
|
|
Three Months Ended
|
||||||||||||
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
||||||||||
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
||||||
|
Restricted stock outstanding as of beginning of period
|
353,103
|
|
|
$
|
7.01
|
|
|
561,089
|
|
|
$
|
7.54
|
|
|
Restricted stock granted
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
|
Restricted stock vested
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
|
Restricted stock outstanding as of end of period
|
353,103
|
|
|
$
|
7.01
|
|
|
561,089
|
|
|
$
|
7.54
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
||||||||||
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
||||||
|
Restricted stock outstanding as of beginning of period
|
553,396
|
|
|
$
|
7.55
|
|
|
696,597
|
|
|
$
|
8.54
|
|
|
Restricted stock granted
|
138,166
|
|
|
6.76
|
|
|
214,878
|
|
|
6.28
|
|
||
|
Restricted stock vested
|
(338,459
|
)
|
|
7.80
|
|
|
(350,386
|
)
|
|
8.76
|
|
||
|
Restricted stock outstanding as of end of period
|
353,103
|
|
|
$
|
7.01
|
|
|
561,089
|
|
|
$
|
7.54
|
|
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
|
Three Months Ended
|
||||||
|
($ in thousands, except per share amounts)
|
September 30, 2017
|
|
June 30, 2017
|
||||
|
GAAP net income (loss) to common shareholders
|
$
|
7,503
|
|
|
$
|
(10,073
|
)
|
|
Less:
|
|
|
|
||||
|
Accretion of de-designated cash flow hedges
(1)
|
(48
|
)
|
|
(73
|
)
|
||
|
Change in fair value of derivative instruments, net
(2)
|
(3,222
|
)
|
|
15,801
|
|
||
|
Loss on sale of investments, net
|
5,211
|
|
|
3,709
|
|
||
|
Fair value adjustments, net
|
(23
|
)
|
|
(30
|
)
|
||
|
Core net operating income to common shareholders
|
$
|
9,421
|
|
|
$
|
9,334
|
|
|
|
|
|
|
||||
|
Weighted average common shares outstanding
|
49,832
|
|
|
49,218
|
|
||
|
Core net operating income per common share
|
$
|
0.19
|
|
|
$
|
0.19
|
|
|
(1)
|
Included in GAAP interest expense and relates to the accretion of the balance remaining in accumulated other comprehensive income as a result of our discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
(2)
|
Amount represents net realized and unrealized gains and losses on derivatives and excludes net periodic interest costs related to these instruments.
|
|
(1)
|
Includes TBA securities, which are accounted for as "derivative assets (liabilities)" on our consolidated balance sheet, at their if-settled cost basis as of the end of the period.
|
|
|
Agency CMBS
|
|
Agency RMBS
|
|
CMBS IO
(2)
|
|
Non-Agency Other
(3)
|
|
Total
|
||||||||||||||
|
($ in thousands)
|
|
30-Year Fixed
(1)
|
|
Adjustable-Rate
|
|
|
|
||||||||||||||||
|
Balance as of December 31, 2016
|
$
|
1,144,555
|
|
|
$
|
—
|
|
|
$
|
1,201,205
|
|
|
$
|
754,546
|
|
|
$
|
111,778
|
|
|
$
|
3,212,084
|
|
|
Purchases
|
234,094
|
|
|
544,050
|
|
|
—
|
|
|
71,803
|
|
|
—
|
|
|
849,947
|
|
||||||
|
Principal payments
|
(45,217
|
)
|
|
(1,549
|
)
|
|
(172,650
|
)
|
|
—
|
|
|
(20,263
|
)
|
|
(239,679
|
)
|
||||||
|
Sales
|
(37,215
|
)
|
|
(1,111
|
)
|
|
(727,841
|
)
|
|
—
|
|
|
(50,871
|
)
|
|
(817,038
|
)
|
||||||
|
(Amortization) accretion
|
(3,587
|
)
|
|
(128
|
)
|
|
(8,568
|
)
|
|
(112,580
|
)
|
|
2,279
|
|
|
(122,584
|
)
|
||||||
|
Change in fair value
|
14,859
|
|
|
(1,903
|
)
|
|
11,636
|
|
|
16,698
|
|
|
(2,576
|
)
|
|
38,714
|
|
||||||
|
Balance as of September 30, 2017
|
$
|
1,307,489
|
|
|
$
|
539,359
|
|
|
$
|
303,782
|
|
|
$
|
730,467
|
|
|
$
|
40,347
|
|
|
$
|
2,921,444
|
|
|
(1)
|
Does not include TBA securities accounted for as "derivative assets (liabilities)" on our consolidated balance sheet.
|
|
(2)
|
Includes Agency and non-Agency issued securities.
|
|
(3)
|
Includes non-Agency CMBS and RMBS.
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
|
RMBS:
|
|
|
|
|
|
|
|
|
||||||||
|
Agency RMBS, 30 year fixed-rate
|
|
$
|
541,262
|
|
|
$
|
539,359
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
TBA securities, 30 year fixed-rate
(1)
|
|
683,813
|
|
|
683,680
|
|
|
—
|
|
|
—
|
|
||||
|
Agency RMBS - adjustable rate
|
|
305,265
|
|
|
303,782
|
|
|
1,214,324
|
|
|
1,201,205
|
|
||||
|
Non-Agency RMBS
|
|
1,113
|
|
|
1,142
|
|
|
33,548
|
|
|
33,562
|
|
||||
|
|
|
1,531,453
|
|
|
1,527,963
|
|
|
1,247,872
|
|
|
1,234,767
|
|
||||
|
CMBS and CMBS IO:
|
|
|
|
|
|
|
|
|
||||||||
|
Fixed-rate Agency CMBS
|
|
$
|
1,314,925
|
|
|
$
|
1,307,489
|
|
|
$
|
1,166,454
|
|
|
$
|
1,144,555
|
|
|
Non-Agency CMBS
|
|
36,328
|
|
|
39,205
|
|
|
72,749
|
|
|
78,216
|
|
||||
|
Agency CMBS IO
|
|
394,380
|
|
|
401,808
|
|
|
411,737
|
|
|
411,898
|
|
||||
|
Non-Agency CMBS IO
|
|
322,735
|
|
|
328,659
|
|
|
346,155
|
|
|
342,648
|
|
||||
|
|
|
2,068,368
|
|
|
2,077,161
|
|
|
1,997,095
|
|
|
1,977,317
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Total MBS portfolio including TBA securities
|
|
$
|
3,599,821
|
|
|
$
|
3,605,124
|
|
|
$
|
3,244,967
|
|
|
$
|
3,212,084
|
|
|
(1)
|
TBA securities are accounted for as "derivative assets (liabilities)" on our consolidated balance sheet at their net carrying value which represents the difference between the market value and the cost basis of the TBA contract as of the end of the period.
|
|
|
September 30, 2017
|
|
December 31, 2016
|
|||||||||||||||||
|
($ in thousands)
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity
(1)
|
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity
(1)
|
|||||||||
|
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
2008 and prior
|
$
|
41,058
|
|
|
$
|
37,869
|
|
|
38
|
|
$
|
57,771
|
|
|
$
|
53,161
|
|
|
34
|
|
|
2009 to 2012
|
135,326
|
|
|
138,475
|
|
|
26
|
|
193,061
|
|
|
198,916
|
|
|
33
|
|||||
|
2013 to 2014
|
20,324
|
|
|
20,701
|
|
|
85
|
|
42,760
|
|
|
43,176
|
|
|
95
|
|||||
|
2015
|
661,113
|
|
|
664,321
|
|
|
102
|
|
683,680
|
|
|
687,214
|
|
|
111
|
|||||
|
2016
|
254,375
|
|
|
256,161
|
|
|
113
|
|
254,781
|
|
|
256,736
|
|
|
122
|
|||||
|
2017
|
230,821
|
|
|
233,728
|
|
|
119
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
1,343,017
|
|
|
$
|
1,351,255
|
|
|
97
|
|
$
|
1,232,053
|
|
|
$
|
1,239,203
|
|
|
97
|
|
|
(1)
|
Months to estimated maturity is an average weighted by the amortized cost of the investment.
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||||||||
|
($ in thousands)
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL
(1)
|
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL
(1)
|
||||||||||
|
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2010
|
$
|
7,157
|
|
|
$
|
7,364
|
|
|
15
|
|
|
$
|
9,456
|
|
|
$
|
9,858
|
|
|
19
|
|
|
2011
|
27,848
|
|
|
29,353
|
|
|
20
|
|
|
35,130
|
|
|
36,897
|
|
|
23
|
|
||||
|
2012
|
77,728
|
|
|
79,667
|
|
|
23
|
|
|
102,378
|
|
|
103,675
|
|
|
27
|
|
||||
|
2013
|
109,705
|
|
|
111,451
|
|
|
29
|
|
|
128,891
|
|
|
129,011
|
|
|
33
|
|
||||
|
2014
|
179,440
|
|
|
182,447
|
|
|
36
|
|
|
201,802
|
|
|
200,260
|
|
|
39
|
|
||||
|
2015
|
177,176
|
|
|
180,448
|
|
|
41
|
|
|
198,016
|
|
|
194,886
|
|
|
45
|
|
||||
|
2016
|
84,943
|
|
|
86,048
|
|
|
48
|
|
|
82,219
|
|
|
79,959
|
|
|
87
|
|
||||
|
2017
|
53,118
|
|
|
53,689
|
|
|
54
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
717,115
|
|
|
$
|
730,467
|
|
|
37
|
|
|
$
|
757,892
|
|
|
$
|
754,546
|
|
|
42
|
|
|
|
|
September 30, 2017
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
Weighted Average Based on Par
|
|||||||||||||||||
|
Coupon
|
|
Par
|
|
Fair
Value
(1)(3)
|
|
Amortized Cost/Cost Basis
(2)(3)
|
|
Loan
Balance
(4)
|
|
Loan Age
(in months)
(4)
|
|
3 Month CPR
(4)(5)
|
|
Duration
(6)
|
|||||||||||
|
($ in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
30-year fixed-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
3.0%
|
|
$
|
248,773
|
|
|
$
|
249,981
|
|
|
$
|
250,632
|
|
|
$
|
233,336
|
|
|
10
|
|
|
2.5
|
%
|
|
6.34
|
|
|
4.0%
|
|
273,326
|
|
|
289,378
|
|
|
290,630
|
|
|
240,621
|
|
|
2
|
|
|
—
|
%
|
|
4.38
|
|
||||
|
TBA 4.0%
|
|
650,000
|
|
|
683,680
|
|
|
683,813
|
|
|
n/a
|
|
n/a
|
|
n/a
|
|
3.32
|
|
|||||||
|
Total 30-year fixed-rate
|
|
$
|
1,172,099
|
|
|
$
|
1,223,039
|
|
|
$
|
1,225,075
|
|
|
$
|
237,150
|
|
|
6
|
|
|
1.2
|
%
|
|
4.21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Adjustable-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
3.1%
(7)
|
|
$
|
294,254
|
|
|
$
|
303,782
|
|
|
$
|
305,265
|
|
|
$
|
270,208
|
|
|
72
|
|
|
17.1
|
%
|
|
2.21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total Agency RMBS (including TBA securities)
|
|
$
|
1,466,353
|
|
|
$
|
1,526,821
|
|
|
$
|
1,530,340
|
|
|
$
|
249,066
|
|
|
30
|
|
|
6.9
|
%
|
|
3.81
|
|
|
(1)
|
Fair value of TBA securities is the current market value of the TBA contract and represents the estimated fair value of the underlying Agency security as of the end of the period.
|
|
(2)
|
Cost basis of TBA securities represents the forward price to be paid for the underlying Agency MBS as if settled.
|
|
(3)
|
The net carrying value of TBA securities, which is the difference between the market value and the cost basis of the TBA securities, was
$(0.1) million
as of
September 30, 2017
and is included on the consolidated balance sheet within "derivative liabilities".
|
|
(4)
|
TBAs are excluded from this calculation as they do not have a defined weighted-average loan balance or age until mortgages have been assigned to the pool.
|
|
(5)
|
Constant prepayment rate ("CPR") represents the 3-month CPR of Agency RMBS held as of date indicated. Securities with no prepayment history are excluded from this calculation.
|
|
(6)
|
Duration is used to measure the market price volatility as interest rates change using dollar value of one basis point ("DV01") methodology.
|
|
(7)
|
Coupon of adjustable-rate Agency RMBS represents the weighted average coupon based on amortized cost.
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
|
($ in thousands)
|
Par Value
|
|
Amortized Cost
|
|
Fair Value
|
|
Par Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||||||
|
Adjustable-rate Agency RMBS by MTR:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
0-12 MTR
|
$
|
47,126
|
|
|
$
|
48,440
|
|
|
$
|
49,580
|
|
|
$
|
335,476
|
|
|
$
|
355,069
|
|
|
$
|
353,887
|
|
|
13-36 MTR
|
2,875
|
|
|
3,057
|
|
|
3,030
|
|
|
225,272
|
|
|
237,642
|
|
|
235,137
|
|
||||||
|
37-60 MTR
|
157,359
|
|
|
164,286
|
|
|
162,810
|
|
|
151,578
|
|
|
160,948
|
|
|
157,945
|
|
||||||
|
Greater than 60 MTR
|
86,894
|
|
|
89,482
|
|
|
88,362
|
|
|
444,932
|
|
|
460,665
|
|
|
454,236
|
|
||||||
|
Total adjustable-rate Agency RMBS
|
$
|
294,254
|
|
|
$
|
305,265
|
|
|
$
|
303,782
|
|
|
$
|
1,157,258
|
|
|
$
|
1,214,324
|
|
|
$
|
1,201,205
|
|
|
|
Nine Months Ended
|
||
|
($ in thousands)
|
September 30, 2017
|
||
|
Balance as of December 31, 2016
(1)
|
$
|
21,612
|
|
|
Net receipt on termination
|
(3,126
|
)
|
|
|
Periodic net cash payments
|
(3,364
|
)
|
|
|
Settlement of variation margin
(2)
|
3,300
|
|
|
|
Change in fair value
|
(14,955
|
)
|
|
|
Accrued interest payable
|
(3,099
|
)
|
|
|
Balance as of September 30, 2017
(1)
|
$
|
368
|
|
|
(1)
|
Represents the net amount recorded in "derivative assets (liabilities)" on the Company's consolidated balance sheets as of period indicated and excludes amounts related to TBA contracts which are also recorded in "derivative assets (liabilities)".
|
|
(2)
|
As of January 2017 margin requirements from fluctuations in fair value of the Company's cleared interest rate swaps are settled daily with the Chicago Mercantile Exchange ("CME").
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
|
($ in thousands)
|
Fair Value
|
|
Amount Pledged
|
|
Related Borrowings
|
|
Fair Value
|
|
Amount Pledged
|
|
Related Borrowings
|
||||||||||||
|
Non-Agency CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
AAA
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
35,405
|
|
|
$
|
35,313
|
|
|
$
|
32,266
|
|
|
AA
|
14,013
|
|
|
—
|
|
|
—
|
|
|
14,127
|
|
|
14,105
|
|
|
11,665
|
|
||||||
|
A
|
18,366
|
|
|
18,365
|
|
|
15,625
|
|
|
18,614
|
|
|
18,549
|
|
|
15,831
|
|
||||||
|
Below A/Not Rated
|
6,826
|
|
|
—
|
|
|
—
|
|
|
10,070
|
|
|
9,873
|
|
|
7,119
|
|
||||||
|
|
$
|
39,205
|
|
|
$
|
18,365
|
|
|
$
|
15,625
|
|
|
$
|
78,216
|
|
|
$
|
77,840
|
|
|
$
|
66,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Non-Agency CMBS IO:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
AAA
|
$
|
273,308
|
|
|
$
|
273,302
|
|
|
$
|
232,717
|
|
|
$
|
290,092
|
|
|
$
|
289,608
|
|
|
$
|
246,412
|
|
|
AA
|
44,474
|
|
|
43,797
|
|
|
37,694
|
|
|
46,986
|
|
|
45,995
|
|
|
40,026
|
|
||||||
|
A
|
753
|
|
|
753
|
|
|
663
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Below A/Not Rated
|
10,124
|
|
|
10,124
|
|
|
8,907
|
|
|
5,570
|
|
|
5,536
|
|
|
4,761
|
|
||||||
|
|
$
|
328,659
|
|
|
$
|
327,976
|
|
|
$
|
279,981
|
|
|
$
|
342,648
|
|
|
$
|
341,139
|
|
|
$
|
291,199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Non-Agency RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Below A/Not Rated
|
$
|
1,142
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
33,562
|
|
|
$
|
31,952
|
|
|
$
|
26,149
|
|
|
|
$
|
1,142
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
33,562
|
|
|
$
|
31,952
|
|
|
$
|
26,149
|
|
|
($ in thousands)
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Agency CMBS
|
$
|
(7,436
|
)
|
|
$
|
(22,295
|
)
|
|
Non-Agency CMBS
|
2,877
|
|
|
5,467
|
|
||
|
Agency CMBS IO
|
7,428
|
|
|
161
|
|
||
|
Non-Agency CMBS IO
|
5,924
|
|
|
(3,507
|
)
|
||
|
Agency RMBS
|
(3,386
|
)
|
|
(13,119
|
)
|
||
|
Non-Agency RMBS
|
29
|
|
|
14
|
|
||
|
De-designated cash flow hedges
|
450
|
|
|
670
|
|
||
|
Accumulated other comprehensive income (loss)
|
$
|
5,886
|
|
|
$
|
(32,609
|
)
|
|
|
Three Months Ended
|
||||||||||||
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
||||||||||
|
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
|
CMBS:
|
|
|
|
|
|
|
|
||||||
|
Coupon and scheduled amortization
|
$
|
9,976
|
|
|
2.90
|
%
|
|
$
|
7,903
|
|
|
3.19
|
%
|
|
Prepayment adjustments
(1)
|
176
|
|
|
0.01
|
%
|
|
(154
|
)
|
|
(0.02
|
)%
|
||
|
|
$
|
10,152
|
|
|
2.91
|
%
|
|
$
|
7,749
|
|
|
3.17
|
%
|
|
Average balance
(2)
|
$
|
1,352,681
|
|
|
|
|
|
$
|
974,240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
CMBS IO:
|
|
|
|
|
|
|
|
|
|||||
|
Coupon and scheduled amortization
|
$
|
6,841
|
|
|
3.73
|
%
|
|
$
|
6,895
|
|
|
3.81
|
%
|
|
Prepayment adjustments
(1)
|
1,209
|
|
|
0.16
|
%
|
|
546
|
|
|
0.07
|
%
|
||
|
|
$
|
8,050
|
|
|
3.89
|
%
|
|
$
|
7,441
|
|
|
3.88
|
%
|
|
Average balance
(2)
|
$
|
734,282
|
|
|
|
|
$
|
724,859
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
RMBS:
|
|
|
|
|
|
|
|
|
|||||
|
Coupon and scheduled amortization
|
$
|
4,693
|
|
|
2.19
|
%
|
|
$
|
6,689
|
|
|
1.92
|
%
|
|
Prepayment adjustments
(1)
|
(124
|
)
|
|
(0.01
|
)%
|
|
(982
|
)
|
|
(0.07
|
)%
|
||
|
|
$
|
4,569
|
|
|
2.18
|
%
|
|
$
|
5,707
|
|
|
1.85
|
%
|
|
Average balance
(2)
|
$
|
856,705
|
|
|
|
|
|
$
|
1,390,401
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total MBS interest income and effective yield:
|
$
|
22,771
|
|
|
2.94
|
%
|
|
$
|
20,897
|
|
|
2.75
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
Total average balance
(2)
:
|
$
|
2,943,668
|
|
|
|
|
$
|
3,089,500
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
||||||||||
|
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
|
CMBS:
|
|
|
|
|
|
|
|
||||||
|
Coupon and scheduled amortization
|
$
|
28,991
|
|
|
2.93
|
%
|
|
$
|
24,241
|
|
|
3.23
|
%
|
|
Prepayment adjustments
(1)
|
2,255
|
|
|
0.17
|
%
|
|
1,016
|
|
|
0.10
|
%
|
||
|
|
$
|
31,246
|
|
|
3.10
|
%
|
|
$
|
25,257
|
|
|
3.33
|
%
|
|
Average balance
(2)
|
$
|
1,308,811
|
|
|
|
|
|
$
|
990,440
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
CMBS IO:
|
|
|
|
|
|
|
|
|
|
||||
|
Coupon and scheduled amortization
|
$
|
21,059
|
|
|
3.75
|
%
|
|
$
|
21,279
|
|
|
3.79
|
%
|
|
Prepayment adjustments
(1)
|
3,619
|
|
|
0.48
|
%
|
|
1,363
|
|
|
0.18
|
%
|
||
|
|
$
|
24,678
|
|
|
4.23
|
%
|
|
$
|
22,642
|
|
|
3.97
|
%
|
|
Average balance
(2)
|
$
|
749,343
|
|
|
|
|
|
$
|
748,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|||
|
Coupon and scheduled amortization
|
$
|
15,341
|
|
|
2.02
|
%
|
|
$
|
21,525
|
|
|
1.91
|
%
|
|
Prepayment adjustments
(1)
|
(1,753
|
)
|
|
(0.17
|
)%
|
|
(1,104
|
)
|
|
(0.07
|
)%
|
||
|
|
$
|
13,588
|
|
|
1.84
|
%
|
|
$
|
20,421
|
|
|
1.84
|
%
|
|
Average balance
(2)
|
$
|
1,014,283
|
|
|
|
|
|
$
|
1,499,309
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total MBS interest income and effective yield:
|
$
|
69,512
|
|
|
2.96
|
%
|
|
$
|
68,320
|
|
|
2.79
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
Total average balance
(2)
:
|
$
|
3,072,437
|
|
|
|
|
$
|
3,237,846
|
|
|
|
||
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
|
(2)
|
Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
|
|
Three Months Ended
|
||||||||||||||
|
|
September 30, 2017 vs. September 30, 2016
|
||||||||||||||
|
|
Increase (Decrease) in Interest Income
|
|
Due to Change In
|
||||||||||||
|
($ in thousands)
|
|
Average Balance
|
|
Coupon and Scheduled Amortization
|
|
Prepayment Adjustments
(1)
|
|||||||||
|
CMBS
|
$
|
2,402
|
|
|
$
|
2,013
|
|
|
$
|
59
|
|
|
$
|
330
|
|
|
CMBS IO
|
609
|
|
|
134
|
|
|
(188
|
)
|
|
663
|
|
||||
|
RMBS
|
(1,137
|
)
|
|
(2,069
|
)
|
|
74
|
|
|
858
|
|
||||
|
Total
|
$
|
1,874
|
|
|
$
|
78
|
|
|
$
|
(55
|
)
|
|
$
|
1,851
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Nine Months Ended
|
||||||||||||||
|
|
September 30, 2017 vs. September 30, 2016
|
||||||||||||||
|
|
Increase (Decrease) in Interest Income
|
|
Due to Change In
|
||||||||||||
|
($ in thousands)
|
|
Average Balance
|
|
Coupon and Scheduled Amortization
|
|
Prepayment Adjustments
(1)
|
|||||||||
|
CMBS
|
$
|
5,989
|
|
|
$
|
4,800
|
|
|
$
|
(50
|
)
|
|
$
|
1,239
|
|
|
CMBS IO
|
2,036
|
|
|
57
|
|
|
(277
|
)
|
|
2,256
|
|
||||
|
RMBS
|
(6,833
|
)
|
|
(6,488
|
)
|
|
304
|
|
|
(649
|
)
|
||||
|
Total
|
$
|
1,192
|
|
|
$
|
(1,631
|
)
|
|
$
|
(23
|
)
|
|
$
|
2,846
|
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for RMBS and prepayment compensation, net of amortization for CMBS and CMBS IO.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Interest expense on repurchase agreement borrowings
|
$
|
9,910
|
|
|
$
|
5,800
|
|
|
$
|
26,269
|
|
|
$
|
17,440
|
|
|
Interest expense on FHLB advances
|
—
|
|
|
343
|
|
|
—
|
|
|
1,118
|
|
||||
|
Accretion of de-designated cash flow hedges
(1)
|
(48
|
)
|
|
(99
|
)
|
|
(220
|
)
|
|
(152
|
)
|
||||
|
Non-recourse collateralized financing
|
27
|
|
|
24
|
|
|
73
|
|
|
72
|
|
||||
|
Total interest expense
|
$
|
9,889
|
|
|
$
|
6,068
|
|
|
$
|
26,122
|
|
|
$
|
18,478
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Average balance of repurchase agreements
|
$
|
2,616,250
|
|
|
$
|
2,536,562
|
|
|
$
|
2,736,834
|
|
|
$
|
2,623,225
|
|
|
Average balance of FHLB advances
|
—
|
|
|
263,000
|
|
|
—
|
|
|
308,022
|
|
||||
|
Average balance of non-recourse collateralized financing
|
5,817
|
|
|
7,386
|
|
|
6,058
|
|
|
7,892
|
|
||||
|
Average balance of borrowings
|
$
|
2,622,067
|
|
|
$
|
2,806,948
|
|
|
$
|
2,742,892
|
|
|
$
|
2,939,139
|
|
|
Cost of funds
(2)
|
1.48
|
%
|
|
0.85
|
%
|
|
1.26
|
%
|
|
0.83
|
%
|
||||
|
(1)
|
Amount recorded in accordance with GAAP related to accretion of the balance remaining in accumulated other comprehensive income as a result of our discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
(2)
|
Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period.
|
|
($ in thousands)
|
Three Months Ended September 30, 2017 vs. September 30, 2016
|
|
Nine Months Ended September 30, 2017 vs. September 30, 2016
|
||||
|
Change in borrowing rates on repurchase agreements and FHLB advances
|
$
|
4,169
|
|
|
$
|
8,927
|
|
|
Change in average balance of repurchase agreements and FHLB advances
|
(402
|
)
|
|
(1,216
|
)
|
||
|
Decrease (increase) in accretion of de-designated cash flow hedges
|
51
|
|
|
(68
|
)
|
||
|
Decrease in non-recourse collateralized financing and other interest expense
|
3
|
|
|
1
|
|
||
|
Total change in interest expense
|
$
|
3,821
|
|
|
$
|
7,644
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Interest expense
|
$
|
9,889
|
|
|
$
|
6,068
|
|
|
$
|
26,122
|
|
|
$
|
18,478
|
|
|
Add: net periodic interest costs of derivative instruments
(1)
|
1,131
|
|
|
155
|
|
|
3,099
|
|
|
2,321
|
|
||||
|
Less: de-designated hedge accretion
(2)
|
48
|
|
|
99
|
|
|
220
|
|
|
152
|
|
||||
|
Adjusted interest expense
|
$
|
11,068
|
|
|
$
|
6,322
|
|
|
$
|
29,441
|
|
|
$
|
20,951
|
|
|
1)
|
Amounts represent net periodic interest costs on effective interest rate swaps outstanding during the period and exclude termination costs and changes in fair value.
|
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to accretion of the balance remaining in accumulated other comprehensive income as a result of our discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
|
Three Months Ended
|
||||||||||||
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
||||||||||
|
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
|
Interest income
|
$
|
23,103
|
|
|
2.95
|
%
|
|
$
|
21,135
|
|
|
2.75
|
%
|
|
Interest expense
|
9,889
|
|
|
1.48
|
%
|
|
6,068
|
|
|
0.85
|
%
|
||
|
Net interest income/spread
|
13,214
|
|
|
1.47
|
%
|
|
15,067
|
|
|
1.90
|
%
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Average interest earning assets
(1)
|
$
|
2,960,595
|
|
|
|
|
$
|
3,110,884
|
|
|
|
||
|
Average balance of borrowings
(2)
|
$
|
2,622,067
|
|
|
|
|
$
|
2,806,948
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
||||||||||||
|
|
2017
|
|
2016
|
||||||||||
|
($ in thousands)
|
Amount
|
|
Yield
|
|
Amount
|
|
Yield
|
||||||
|
Interest income
|
$
|
70,378
|
|
|
2.97
|
%
|
|
$
|
69,040
|
|
|
2.80
|
%
|
|
Interest expense
|
26,122
|
|
|
1.26
|
%
|
|
18,478
|
|
|
0.83
|
%
|
||
|
Net interest income/spread
|
$
|
44,256
|
|
|
1.71
|
%
|
|
$
|
50,562
|
|
|
1.97
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
Average interest earning assets
(1)
|
$
|
3,090,313
|
|
|
|
|
$
|
3,260,510
|
|
|
|
||
|
Average balance of borrowings
(2)
|
$
|
2,742,892
|
|
|
|
|
$
|
2,939,139
|
|
|
|
||
|
(1)
|
Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
|
(2)
|
Average balances are calculated as a simple average of the daily borrowings outstanding for both repurchase agreement and non-recourse collateralized financing.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Net interest income
|
$
|
13,214
|
|
|
$
|
15,067
|
|
|
$
|
44,256
|
|
|
$
|
50,562
|
|
|
Add: drop income
|
3,902
|
|
|
—
|
|
|
5,253
|
|
|
—
|
|
||||
|
Add: net periodic interest costs
(1)
|
(1,131
|
)
|
|
(155
|
)
|
|
(3,099
|
)
|
|
(2,321
|
)
|
||||
|
Less: de-designated hedge accretion
(2)
|
(48
|
)
|
|
(99
|
)
|
|
(220
|
)
|
|
(152
|
)
|
||||
|
Adjusted net interest income
|
$
|
15,937
|
|
|
$
|
14,813
|
|
|
$
|
46,190
|
|
|
$
|
48,089
|
|
|
(1)
|
Amounts represent net periodic interest costs on effective interest rate swaps outstanding during the period and exclude termination costs and changes in fair value.
|
|
(2)
|
Amount recorded in accordance with GAAP related to accretion of the balance remaining in accumulated other comprehensive income as a result of our discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
|
|
Three Months Ended
|
||||||||||||||||||||||
|
|
|
September 30,
|
||||||||||||||||||||||
|
($ in thousands)
|
|
2017
|
|
2016
|
||||||||||||||||||||
|
Type of Derivative Instrument
|
|
Net Periodic Interest Costs
|
|
Change in
Fair Value
(1)(2)
|
|
Total
|
|
Net Periodic Interest Costs
|
|
Change in Fair Value
(1)
|
|
Total
|
||||||||||||
|
Interest rate swaps
|
|
$
|
(1,131
|
)
|
|
$
|
421
|
|
|
$
|
(710
|
)
|
|
$
|
(155
|
)
|
|
$
|
(266
|
)
|
|
$
|
(421
|
)
|
|
TBA securities
|
|
—
|
|
|
6,703
|
|
|
6,703
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Eurodollar futures
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,830
|
|
|
2,830
|
|
||||||
|
Loss on derivative instruments, net
|
|
$
|
(1,131
|
)
|
|
$
|
7,124
|
|
|
$
|
5,993
|
|
|
$
|
(155
|
)
|
|
$
|
2,564
|
|
|
$
|
2,409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
Nine Months Ended
|
||||||||||||||||||||||
|
|
|
September 30,
|
||||||||||||||||||||||
|
|
|
2017
|
|
2016
|
||||||||||||||||||||
|
Type of Derivative Instrument
|
|
Net Periodic Interest Costs
|
|
Change in
Fair Value
(1)(2)
|
|
Total
|
|
Net Periodic Interest Costs
|
|
Change in Fair Value
(1)
|
|
Total
|
||||||||||||
|
Interest rate swaps
|
|
$
|
(3,099
|
)
|
|
$
|
(14,954
|
)
|
|
$
|
(18,053
|
)
|
|
$
|
(2,321
|
)
|
|
$
|
(46,290
|
)
|
|
$
|
(48,611
|
)
|
|
TBA securities
|
|
—
|
|
|
8,419
|
|
|
8,419
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Eurodollar futures
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13,542
|
)
|
|
(13,542
|
)
|
||||||
|
Loss on derivative instruments, net
|
|
$
|
(3,099
|
)
|
|
$
|
(6,535
|
)
|
|
$
|
(9,634
|
)
|
|
$
|
(2,321
|
)
|
|
$
|
(59,832
|
)
|
|
$
|
(62,153
|
)
|
|
(1)
|
Changes in fair value for interest rate swaps and Eurodollar futures include unrealized gains (losses) from current and forward starting derivative instruments and realized gains (losses) from terminated derivative instruments.
|
|
(2)
|
Change in fair value for TBA securities includes unrealized gains (losses) from open TBA contracts and realized gains (losses) on terminated positions.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Average notional balance
|
$
|
2,668,478
|
|
|
$
|
305,000
|
|
|
$
|
2,011,355
|
|
|
$
|
549,617
|
|
|
Weighted average net pay-fixed rate
|
1.37
|
%
|
|
0.64
|
%
|
|
1.30
|
%
|
|
1.06
|
%
|
||||
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
September 30, 2017
|
|
September 30, 2017
|
||||||||||||
|
($ in thousands)
|
|
Average Cost Basis
|
|
Drop
Income
(1)
|
|
Average Cost Basis
|
|
Drop
Income
(1)
|
||||||||
|
TBA securities:
|
|
|
|
|
|
|
|
|
||||||||
|
3.0% 30-year
|
|
$
|
119,528
|
|
|
$
|
563
|
|
|
$
|
69,539
|
|
|
$
|
960
|
|
|
4.0% 30-year
|
|
677,956
|
|
|
3,339
|
|
|
287,298
|
|
|
4,293
|
|
||||
|
Total TBA securities
|
|
$
|
797,484
|
|
|
$
|
3,902
|
|
|
$
|
356,837
|
|
|
$
|
5,253
|
|
|
(1)
|
Drop income is recognized in "gain (loss) on derivatives, net" on our consolidated statements of comprehensive income.
|
|
|
Three Months Ended
|
||||||||||||||
|
|
September 30,
|
||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||
|
($ in thousands)
|
Amortized cost basis sold
|
|
Gain (loss) on sale of investments, net
|
|
Amortized cost basis sold
|
|
Gain (loss) on sale of investments, net
|
||||||||
|
Agency RMBS
|
$
|
398,662
|
|
|
$
|
(5,160
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Agency CMBS
|
13,484
|
|
|
(51
|
)
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
412,146
|
|
|
$
|
(5,211
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Nine Months Ended
|
||||||||||||||
|
|
September 30,
|
||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||
|
($ in thousands)
|
Amortized cost basis sold
|
|
Gain (loss) on sale of investments, net
|
|
Amortized cost basis sold
|
|
Gain (loss) on sale of investments, net
|
||||||||
|
Agency RMBS
|
$
|
728,952
|
|
|
$
|
(12,392
|
)
|
|
$
|
57,188
|
|
|
$
|
(3,010
|
)
|
|
Agency CMBS
|
206,470
|
|
|
523
|
|
|
—
|
|
|
—
|
|
||||
|
Non-Agency CMBS
|
34,506
|
|
|
1,199
|
|
|
34,868
|
|
|
(1,228
|
)
|
||||
|
Non-Agency RMBS
|
16,365
|
|
|
42
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
986,293
|
|
|
$
|
(10,628
|
)
|
|
$
|
92,056
|
|
|
$
|
(4,238
|
)
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Agency CMBS
|
$
|
2,334
|
|
|
$
|
(1,226
|
)
|
|
$
|
14,859
|
|
|
$
|
40,093
|
|
|
Non-Agency CMBS
|
(403
|
)
|
|
(377
|
)
|
|
(2,591
|
)
|
|
2,036
|
|
||||
|
Agency CMBS IO
|
1,032
|
|
|
1,616
|
|
|
7,268
|
|
|
4,187
|
|
||||
|
Non-Agency CMBS IO
|
1,101
|
|
|
2,131
|
|
|
9,431
|
|
|
5,832
|
|
||||
|
Agency RMBS
|
2,120
|
|
|
(1,765
|
)
|
|
9,734
|
|
|
12,548
|
|
||||
|
Non-Agency RMBS
|
8
|
|
|
390
|
|
|
14
|
|
|
802
|
|
||||
|
Unrealized gain on available-for-sale investments
|
$
|
6,192
|
|
|
$
|
769
|
|
|
$
|
38,715
|
|
|
$
|
65,498
|
|
|
|
Repurchase Agreements
|
|
Net TBA Position
(1)
|
||||||||||||||||
|
($ in thousands)
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
|
Maximum Balance Outstanding During the Quarter Ended
|
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
||||||||||
|
September 30, 2017
|
$
|
2,519,230
|
|
|
$
|
2,616,250
|
|
|
$
|
2,801,418
|
|
|
$
|
683,813
|
|
|
$
|
745,270
|
|
|
June 30, 2017
|
2,540,759
|
|
|
2,753,019
|
|
|
2,826,005
|
|
|
416,312
|
|
|
305,720
|
|
|||||
|
March 31, 2017
|
2,825,945
|
|
|
2,843,733
|
|
|
2,913,617
|
|
|
—
|
|
|
—
|
|
|||||
|
December 31, 2016
|
2,898,952
|
|
|
2,768,769
|
|
|
2,938,745
|
|
|
—
|
|
|
—
|
|
|||||
|
September 30, 2016
|
2,478,278
|
|
|
2,536,562
|
|
|
2,599,491
|
|
|
—
|
|
|
—
|
|
|||||
|
(1)
|
Balance outstanding as of quarter end and average balance outstanding for the quarter ended for net TBA position are reported at cost (as if settled).
|
|
|
September 30, 2017
|
|
June 30, 2017
|
|
March 31, 2017
|
|
December 31, 2016
|
|
September 30, 2016
|
|||||
|
Agency CMBS and RMBS
|
5.0
|
%
|
|
5.0
|
%
|
|
5.0
|
%
|
|
5.0
|
%
|
|
5.1
|
%
|
|
Non-Agency CMBS and RMBS
|
15.0
|
%
|
|
18.0
|
%
|
|
15.8
|
%
|
|
16.3
|
%
|
|
17.0
|
%
|
|
CMBS IO
|
15.0
|
%
|
|
15.0
|
%
|
|
15.3
|
%
|
|
15.4
|
%
|
|
15.4
|
%
|
|
|
September 30, 2017
|
||||||
|
($ in thousands)
|
Amount Outstanding
|
|
Equity at Risk
|
||||
|
Well Fargo Bank, N.A. and affiliates
|
$
|
349,965
|
|
|
$
|
57,992
|
|
|
JP Morgan Securities, LLC
|
270,883
|
|
|
30,803
|
|
||
|
|
$
|
620,848
|
|
|
$
|
88,795
|
|
|
|
December 31, 2016
|
||||||
|
($ in thousands)
|
Amount Outstanding
|
|
Equity at Risk
|
||||
|
Well Fargo Bank, N.A. and affiliates
|
$
|
342,160
|
|
|
$
|
62,041
|
|
|
South Street Financial Corporation
|
597,394
|
|
|
38,770
|
|
||
|
JP Morgan Securities, LLC
|
212,921
|
|
|
35,658
|
|
||
|
|
$
|
1,152,475
|
|
|
$
|
136,469
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||
|
($ in thousands)
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
||||||||
|
North America
|
$
|
1,685,493
|
|
|
$
|
1,840,749
|
|
|
$
|
2,105,337
|
|
|
$
|
2,309,391
|
|
|
Asia
|
521,832
|
|
|
548,717
|
|
|
421,991
|
|
|
443,098
|
|
||||
|
Europe
|
311,905
|
|
|
328,537
|
|
|
371,624
|
|
|
397,351
|
|
||||
|
|
$
|
2,519,230
|
|
|
$
|
2,718,003
|
|
|
$
|
2,898,952
|
|
|
$
|
3,149,840
|
|
|
($ in thousands)
|
Tax Hedge Loss Deduction
|
||
|
2017
|
$
|
21,542
|
|
|
2018
|
21,175
|
|
|
|
2019
|
16,937
|
|
|
|
2020 - 2026
|
12,383
|
|
|
|
|
$
|
72,037
|
|
|
($ in thousands)
|
|
Payments due by period
|
||||||||||||||||||
|
Contractual Obligations:
|
|
Total
|
|
< 1 year
|
|
1-3 years
|
|
3-5 years
|
|
> 5 years
|
||||||||||
|
Repurchase agreements
(1)
|
|
$
|
2,557,279
|
|
|
$
|
2,557,279
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Non-recourse collateralized financing
(2)
|
|
5,786
|
|
|
1,669
|
|
|
2,199
|
|
|
1,207
|
|
|
711
|
|
|||||
|
Operating lease obligations
|
|
544
|
|
|
214
|
|
|
330
|
|
|
—
|
|
|
—
|
|
|||||
|
Total
|
|
$
|
2,563,609
|
|
|
$
|
2,559,162
|
|
|
$
|
2,529
|
|
|
$
|
1,207
|
|
|
$
|
711
|
|
|
•
|
Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations;
|
|
•
|
Our views on the effect of actual or proposed actions of the U.S. Federal Reserve and the FOMC with respect to monetary policy (including the targeted Federal Funds Rate), and the potential impact of these actions on interest rates, inflation or unemployment;
|
|
•
|
The effect of regulatory initiatives of the Federal Reserve (including the FOMC) and other financial regulators;
|
|
•
|
Our financing strategy including our target leverage ratios, our use of TBA dollar roll transactions, and anticipated trends in financing costs, and our hedging strategy including changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;
|
|
•
|
Our investment portfolio composition and target investments;
|
|
•
|
Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investments;
|
|
•
|
Our liquidity and ability to access financing, and the anticipated availability and cost of financing;
|
|
•
|
Our stock repurchase activity and the impact of stock repurchases;
|
|
•
|
Our use of and restrictions on using our tax NOL carryforward;
|
|
•
|
The status of pending litigation;
|
|
•
|
The competitive environment in the future, including competition for investments and the availability of financing;
|
|
•
|
Estimates of future interest expenses, including related to the Company's repurchase agreements and derivative instruments;
|
|
•
|
The status of regulatory rule-making or review processes and the status of reform efforts and other business developments in the repurchase agreement financing market;
|
|
•
|
Market, industry and economic trends, how these trends and related economic data may impact the behavior of market participants and financial regulators; and
|
|
•
|
Market interest rates and market spreads.
|
|
•
|
the risks and uncertainties referenced in this
Quarterly
Report on Form
10-Q
, particularly those set forth under and incorporated by reference into Part II, Item 1A, “Risk Factors”;
|
|
•
|
our ability to find suitable reinvestment opportunities;
|
|
•
|
changes in domestic economic conditions;
|
|
•
|
changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;
|
|
•
|
our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;
|
|
•
|
the impact on markets and asset prices from the Federal Reserve's balance sheet normalization process through the reduction in its holdings of Agency RMBS and U.S. Treasuries
|
|
•
|
actual or anticipated changes in Federal Reserve monetary policy;
|
|
•
|
adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies including in particular China, Japan, the European Union, and the United Kingdom;
|
|
•
|
uncertainty concerning the long-term fiscal health and stability of the United States;
|
|
•
|
the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;
|
|
•
|
the cost and availability of new equity capital;
|
|
•
|
changes in our use of leverage;
|
|
•
|
changes to our investment strategy, operating policies, dividend policy or asset allocations;
|
|
•
|
the quality of performance of third-party servicer providers of our loans and loans underlying our securities;
|
|
•
|
the level of defaults by borrowers on loans we have securitized;
|
|
•
|
changes in our industry;
|
|
•
|
increased competition;
|
|
•
|
changes in government regulations affecting our business;
|
|
•
|
changes in the repurchase agreement financing markets and other credit markets;
|
|
•
|
changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;
|
|
•
|
uncertainty regarding continued government support of the U.S financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including the resolution of the conservatorship of Fannie Mae and Freddie Mac;
|
|
•
|
the composition of the Board of Governors of the Federal Reserve System;
|
|
•
|
ownership shifts under Section 382 that further limit the use of our tax NOL carryforward; and
|
|
•
|
exposure to current and future claims and litigation.
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||
|
|
|
Percentage Change in
|
|
Percentage Change in
|
||||||||
|
Parallel Shift in Interest Rates
|
|
Market Value of Investments
(1)
|
|
Shareholders' Equity
|
|
Net Interest Income and Net Periodic Interest Costs
(2)
|
|
Market Value of Investments
(1)
|
|
Shareholders' Equity
|
|
Net Interest Income and Net Periodic Interest Costs
(2)
|
|
+100
|
|
(1.3)%
|
|
(9.1)%
|
|
10.3%
|
|
(0.6)%
|
|
(4.4)%
|
|
(42.4)%
|
|
+50
|
|
(0.5)%
|
|
(3.7)%
|
|
5.6%
|
|
(0.3)%
|
|
(1.9)%
|
|
(20.7)%
|
|
-50
|
|
0.3%
|
|
2.1%
|
|
(7.2)%
|
|
0.2%
|
|
1.2%
|
|
18.7%
|
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
|
(2)
|
Includes changes in net interest income as well as net periodic interest costs on our interest rate swaps recorded in "gain (loss) on derivatives instruments, net".
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||
|
Basis Point Change in
|
|
Percentage Change in
|
||||||||
|
2-year UST
|
|
10-year UST
|
|
Market Value of Investments
(1)
|
|
Shareholders' Equity
|
|
Market Value of Investments
(1)
|
|
Shareholders' Equity
|
|
+25
|
|
+50
|
|
(0.5)%
|
|
(3.6)%
|
|
0.1%
|
|
0.5%
|
|
+25
|
|
+0
|
|
(0.1)%
|
|
(0.6)%
|
|
(0.4)%
|
|
(2.5)%
|
|
+50
|
|
+25
|
|
(0.3)%
|
|
(2.3)%
|
|
(0.5)%
|
|
(3.2)%
|
|
+50
|
|
+100
|
|
(1.2)%
|
|
(8.1)%
|
|
0.1%
|
|
0.4%
|
|
-10
|
|
-50
|
|
(0.2)%
|
|
1.5%
|
|
(0.3)%
|
|
(2.3)%
|
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
|
Basis Point Change in Market Spreads
|
|
Percentage Change in Projected
Market Value of Investments
|
||
|
|
|
September 30, 2017
|
|
December 31, 2016
|
|
+50
|
|
(2.6)%
|
|
(2.2)%
|
|
+25
|
|
(1.3)%
|
|
(1.1)%
|
|
-25
|
|
1.3%
|
|
1.1%
|
|
-50
|
|
2.6%
|
|
2.3%
|
|
($ in thousands)
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Fannie Mae
|
$
|
11,200
|
|
|
$
|
18,957
|
|
|
Freddie Mac
|
390,608
|
|
|
392,941
|
|
||
|
Non-Agency CMBS IO
|
328,659
|
|
|
342,648
|
|
||
|
|
$
|
730,467
|
|
|
$
|
754,546
|
|
|
|
September 30, 2017
|
|
June 30, 2017
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||||||
|
($ in thousands)
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
|
Net Premium
|
|
WAC
|
||||||||
|
0-12 MTR
|
$
|
1,313
|
|
|
3.44%
|
|
$
|
7,637
|
|
|
3.36%
|
|
$
|
17,671
|
|
|
3.24%
|
|
$
|
19,593
|
|
|
3.17%
|
|
13-36 MTR
|
182
|
|
|
4.52%
|
|
3,278
|
|
|
3.14%
|
|
7,307
|
|
|
3.07%
|
|
12,369
|
|
|
3.18%
|
||||
|
37-60 MTR
|
6,928
|
|
|
3.16%
|
|
11,074
|
|
|
3.07%
|
|
11,651
|
|
|
3.38%
|
|
10,441
|
|
|
3.51%
|
||||
|
> 60 MTR
|
2,588
|
|
|
2.58%
|
|
7,085
|
|
|
2.57%
|
|
11,744
|
|
|
2.68%
|
|
14,663
|
|
|
2.73%
|
||||
|
30-year fixed-rate
|
19,163
|
|
|
3.52%
|
|
—
|
|
|
—%
|
|
—
|
|
|
—%
|
|
—
|
|
|
—%
|
||||
|
Total
|
$
|
30,174
|
|
|
3.35%
|
|
$
|
29,074
|
|
|
2.98%
|
|
$
|
48,373
|
|
|
3.04%
|
|
$
|
57,066
|
|
|
3.05%
|
|
Par balance
|
$
|
816,353
|
|
|
|
|
$
|
715,015
|
|
|
|
|
$
|
1,033,735
|
|
|
|
|
$
|
1,157,258
|
|
|
|
|
Premium, net as a % of par value
|
3.7
|
%
|
|
|
|
4.1
|
%
|
|
|
|
4.7
|
%
|
|
|
|
4.9
|
%
|
|
|
||||
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
|
|
OTHER INFORMATION
|
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
|
Exhibit No.
|
Description
|
|
3.1
|
|
|
3.2
|
|
|
10.23.4
|
|
|
10.34
|
|
|
12.1
|
|
|
31.1
|
|
|
31.2
|
|
|
32.1
|
|
|
101
|
The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended September 30, 2017, formatted in XBRL (Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets (unaudited), (ii) Consolidated Statements of Comprehensive Income (unaudited), (iii) Consolidated Statement of Shareholders' Equity (unaudited), (iv) Consolidated Statements of Cash Flows (unaudited), and (v) Notes to the Unaudited Consolidated Financial Statements.
|
|
|
|
DYNEX CAPITAL, INC.
|
|
|
|
|
|
|
|
|
|
Date:
|
November 3, 2017
|
/s/ Byron L. Boston
|
|
|
|
Byron L. Boston
|
|
|
|
Chief Executive Officer, President,
|
|
|
|
Co-Chief Investment Officer, and Director
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
Date:
|
November 3, 2017
|
/s/ Stephen J. Benedetti
|
|
|
|
Stephen J. Benedetti
|
|
|
|
Executive Vice President, Chief Financial Officer and Chief Operating Officer
|
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|